BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35565216)

  • 1. Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions.
    Khaleel S; Katims A; Cumarasamy S; Rosenzweig S; Attalla K; Hakimi AA; Mehrazin R
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomics and Texture Analysis to Detect von Hippel-Lindau (VHL) Mutation in Clear Cell Renal Cell Carcinoma.
    Greco F; D'Andrea V; Beomonte Zobel B; Mallio CA
    Curr Issues Mol Biol; 2024 Apr; 46(4):3236-3250. PubMed ID: 38666933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
    Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study.
    Liu DH; Dani KA; Reddy SS; Lei X; Demirjian NL; Hwang DH; Varghese BA; Rhie SK; Yap FY; Quinn DI; Siddiqi I; Aron M; Vaishampayan U; Zahoor H; Cen SY; Gill IS; Duddalwar VA
    Oncology; 2023; 101(6):375-388. PubMed ID: 37080171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomics in renal cell carcinoma.
    Alessandrino F; Shinagare AB; Bossé D; Choueiri TK; Krajewski KM
    Abdom Radiol (NY); 2019 Jun; 44(6):1990-1998. PubMed ID: 29713740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics-Definition, Current Advances, and Future Directions.
    Gopal N; Yazdian Anari P; Turkbey E; Jones EC; Malayeri AA
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.
    Gao J; Ye F; Han F; Wang X; Jiang H; Zhang J
    Front Oncol; 2021; 11():739815. PubMed ID: 34692518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the ADAM12 Expression in Clear Cell Renal Cell Carcinoma: A Radiogenomic Analysis on CT Imaging.
    Greco F; Panunzio A; Bernetti C; Tafuri A; Beomonte Zobel B; Mallio CA
    Acad Radiol; 2024 Mar; ():. PubMed ID: 38485610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
    Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
    World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review.
    Infante T; Cavaliere C; Punzo B; Grimaldi V; Salvatore M; Napoli C
    Circ Cardiovasc Imaging; 2021 Dec; 14(12):1133-1146. PubMed ID: 34915726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extendable and explainable deep learning for pan-cancer radiogenomics research.
    Liu Q; Hu P
    Curr Opin Chem Biol; 2022 Feb; 66():102111. PubMed ID: 34999476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors.
    Ismail M; Craig S; Ahmed R; de Blank P; Tiwari P
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status.
    Kocak B; Durmaz ES; Ates E; Ulusan MB
    AJR Am J Roentgenol; 2019 Mar; 212(3):W55-W63. PubMed ID: 30601030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model.
    Chen X; Zhou Z; Hannan R; Thomas K; Pedrosa I; Kapur P; Brugarolas J; Mou X; Wang J
    Phys Med Biol; 2018 Oct; 63(21):215008. PubMed ID: 30277889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background, applications and challenges of radiogenomics in genitourinary tumor.
    Liu L; Yi X; Lu C; Pang Y; Zu X; Chen M; Guan X
    Am J Cancer Res; 2021; 11(5):1936-1945. PubMed ID: 34094662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.